1654 related articles for article (PubMed ID: 28978359)
1. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
2. N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.
Savastano A; Klafki H; Haußmann U; Oberstein TJ; Muller P; Wirths O; Wiltfang J; Bayer TA
J Alzheimers Dis; 2016; 49(1):101-10. PubMed ID: 26529393
[TBL] [Abstract][Full Text] [Related]
3. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
[TBL] [Abstract][Full Text] [Related]
4. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
5. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody.
Antonios G; Saiepour N; Bouter Y; Richard BC; Paetau A; Verkkoniemi-Ahola A; Lannfelt L; Ingelsson M; Kovacs GG; Pillot T; Wirths O; Bayer TA
Acta Neuropathol Commun; 2013 Sep; 1():56. PubMed ID: 24252153
[TBL] [Abstract][Full Text] [Related]
6. The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.
Walter S; Jumpertz T; Hüttenrauch M; Ogorek I; Gerber H; Storck SE; Zampar S; Dimitrov M; Lehmann S; Lepka K; Berndt C; Wiltfang J; Becker-Pauly C; Beher D; Pietrzik CU; Fraering PC; Wirths O; Weggen S
Acta Neuropathol; 2019 Feb; 137(2):239-257. PubMed ID: 30426203
[TBL] [Abstract][Full Text] [Related]
7. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
[TBL] [Abstract][Full Text] [Related]
8. N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer's pathophysiology.
Rostagno A; Cabrera E; Lashley T; Ghiso J
Transl Neurodegener; 2022 Jun; 11(1):30. PubMed ID: 35641972
[TBL] [Abstract][Full Text] [Related]
9. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
Kumar S; Lemere CA; Walter J
Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
[TBL] [Abstract][Full Text] [Related]
11. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
12. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
13. Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.
Frost JL; Le KX; Cynis H; Ekpo E; Kleinschmidt M; Palmour RM; Ervin FR; Snigdha S; Cotman CW; Saido TC; Vassar RJ; St George-Hyslop P; Ikezu T; Schilling S; Demuth HU; Lemere CA
Am J Pathol; 2013 Aug; 183(2):369-81. PubMed ID: 23747948
[TBL] [Abstract][Full Text] [Related]
14. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice.
McGowan E; Pickford F; Kim J; Onstead L; Eriksen J; Yu C; Skipper L; Murphy MP; Beard J; Das P; Jansen K; DeLucia M; Lin WL; Dolios G; Wang R; Eckman CB; Dickson DW; Hutton M; Hardy J; Golde T
Neuron; 2005 Jul; 47(2):191-199. PubMed ID: 16039562
[TBL] [Abstract][Full Text] [Related]
15. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
16. Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N‑truncated Abeta in sporadic Alzheimer disease cases and mouse models.
Bouter Y; Lopez Noguerola JS; Tucholla P; Crespi GA; Parker MW; Wiltfang J; Miles LA; Bayer TA
Acta Neuropathol; 2015 Nov; 130(5):713-29. PubMed ID: 26467270
[TBL] [Abstract][Full Text] [Related]
17. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
18. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
19. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
[TBL] [Abstract][Full Text] [Related]
20. Oligomeric pyroglutamate amyloid-β is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapy.
Wirths O; Hillmann A; Pradier L; Härtig W; Bayer TA
J Alzheimers Dis; 2013; 35(4):741-9. PubMed ID: 23481684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
